Status:
COMPLETED
Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™)
Lead Sponsor:
AstraZeneca
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine whether food has any effect on a single dose of Cediranib (AZD2171, Recentin™)followed by an assessment of the safety and tolerability of fixed daily dosing i...
Eligibility Criteria
Inclusion
- Clinical diagnosis of advanced solid tumour.
- Ability to eat a high fat breakfast
Exclusion
- Poorly controlled high blood pressure.
- History of significant gastrointestinal problems
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00306891
Start Date
June 1 2006
End Date
September 1 2008
Last Update
November 1 2012
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Glasgow, United Kingdom
2
Research Site
Headington, United Kingdom
3
Research Site
London, United Kingdom
4
Research Site
Manchester, United Kingdom